Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Liquid Biopsy Market to 2027-Regional Analysis & Forecasts by Product & Services ; Sample ; Circulating Biomarker ; Application ; End User ; & Country-Regional Analysis & Market Forecasts

Published by The Insight Partners Product code 954603
Published Content info 143 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Liquid Biopsy Market to 2027-Regional Analysis & Forecasts by Product & Services ; Sample ; Circulating Biomarker ; Application ; End User ; & Country-Regional Analysis & Market Forecasts
Published: August 14, 2020 Content info: 143 Pages
Description

Title:
Europe Liquid Biopsy Market to 2027 - Regional Analysis and Forecasts by Product & Services (Equipment, Reagents & Kits and Services); Sample (Blood Based, Urine Based and Other samples); Circulating Biomarker (Circulating Tumor Cells (CTC), Exosomes and Free Nucleic Acid); Application (Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics and Other Applications); End User (Academic & Research Institutes, Hospitals, Reference Laboratories and Other End Users); and, Country - Regional Analysis and Market Forecasts by Product & Services, Sample, Circulating Biomarker, Application and End User .

Europe, the liquid biopsy market, is anticipated to reach US$ 2,251.12 Mn in 2027 from US$ 1,097.82 Mn in 2019. The market is projected to grow with a CAGR of 9.5% from 2019-2027.

The liquid biopsy market is growing primarily due to government and global health organizations initiatives. Restraining factors, such as low sensitivity of liquid biopsy, is likely to damage the growth of the market in the coming years. On the other hand, rising liquid biopsy due to growing application and advancements is expected to have a positive impact on the growth of the Europe liquid biopsy market in the coming years.

Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.

The liquid biopsy test is conducted to detect cancer at an early stage. The test isperformed either on a blood sample to identify cancer cells present in the in blood stream, or on the DNA extracted from tumor cells. The government for early detection of cancer takes various initiatives. For instance, the National Institutes of Health (NIH) started a new initiative called Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment. The purposes of this initiative are to establish a Public-Private Partnership Program for the development of new or validate existing technologies, methods, and assays for the capture and quantification of tumor-associated cells, RNA, DNA, or exosomes in body fluids of patients with an early-stage disease or those at high risk. This initiative emphasis early cancer detection, distinguishing between aggressive from nonaggressive cancers, and to differentiate benign disease from cancer.

The NCI'scommitment of funds towards R&D of clinical advanced technology will encourage the investigators to expand their research for early detection and accelerate clinical adoption of these promising technologies.

European countries are also taking initiatives for early detection of cancer. For instance, the Innovative Medicines Initiative funded the CANCER-ID project, started on 1January 2015. It is a public-private partnership between the EU and the European pharmaceutical industry, which includes 38 partners from 13 European countries, along with groups from the US and a company in Singapore. These partners are brought together to develop and validate standardized operating procedures for liquid biopsies. Such increasing initiatives for liquid biopsy, it is likely to boost the growth of the global liquid biopsy market during the forecast period.

In 2019, the reagents & kits segment accounted for the largest market share in the Europe liquid biopsy market based on the product & services, and the similar segment is estimated to mark the highest CAGR in the market during the forecast period, owing to the availability of complete set of kits for liquid biopsy.

Moreover, the European Society for Medical Oncology (ESMO) is the leading professional organization for medical oncology, is continuing to help oncology professionals by helping them to deliver optimal care to their cancer patients in such situations. The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. However, due to growing COVID-19, the supply of diagnostics kits and assays are delayed because of growing quarantine time and shutting down all business operations. Europe is facing the massive impact of an outbreak due to exponential growth of infections in the region. As per data published by public sources, till March 26, Europe had an estimated 250,000 number of infected patients in the region. The outbreak badly hits countries such as Italy, Spain, Germany, France, and the UK.

Some of the significant primary and secondary sources for liquid biopsy included in the report are Biotechnology and Biological Sciences Research Council (BBSRC), British Journal of Surgery (BJS), Cancer Center Amsterdam (CCA), International Diabetes Federation (IDF), an

Reasons to Buy

To understand the liquid biopsy market landscape and identify market segments that are most likely to guarantee a strong return

Stay ahead of the race by comprehending the ever-changing competitive landscape for liquid biopsy market

Efficiently plan M&A and partnership deals in liquid biopsy market by identifying market segments with the most promising probable sales

Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form liquid biopsy market

Obtain market revenue forecast for market by various segments from 2018-2027 in Europe region.

Table of Contents
Product Code: TIPRE00013007

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Liquid Biopsy Market - By Product & Service
    • 1.3.2 Europe Liquid Biopsy Market - By Sample
    • 1.3.3 Europe Liquid Biopsy Market - By Circulating Biomarker
    • 1.3.4 Europe Liquid Biopsy Market - By Application
    • 1.3.5 Europe Liquid Biopsy Market - By End User
    • 1.3.6 Europe Liquid Biopsy Market - By Country

2. Europe Liquid Biopsy Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Liquid Biopsy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe Liquid Biopsy Market - Europe PEST Analysis
  • 4.3 Expert Opinion

5. Europe Liquid Biopsy - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Government and Global Health Organizations Initiatives
  • 5.2 Key Restraints
    • 5.2.1 Low Sensitivity of Liquid Biopsy
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Liquid Biopsy Due to Growing Application and Advancements
  • 5.4 Future Trends
    • 5.4.1 Consistent Launch of New Products
  • 5.5 Impact Analysis

6. Liquid Biopsy Market - Europe Analysis

  • 6.1 Europe Liquid Biopsy Market Revenue Forecasts and Analysis

7. Liquid Biopsy Market Analysis - By Product & Services

  • 7.1 Overview
  • 7.2 Liquid Biopsy Market Revenue Share, by Product& Service (2019 and 2027)
  • 7.3 Equipment
    • 7.3.1 Overview
  • 7.4 Equipment: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Reagents & Kits
    • 7.5.1 Overview
    • 7.5.2 Reagents & Kits: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Services
    • 7.6.1 Overview
    • 7.6.2 Services: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

8. Liquid Biopsy Market Analysis - By Sample

  • 8.1 Overview
  • 8.2 Liquid Biopsy Market, by Sample, 2019 and 2027 (%)
  • 8.3 Blood Based
    • 8.3.1 Overview
    • 8.3.2 Blood Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Urine Based
    • 8.4.1 Overview
    • 8.4.2 Urine Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Other Samples
    • 8.5.1 Overview
  • 8.6 Other Samples: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

9. Liquid Biopsy Market Analysis - By Circulating Biomarker

  • 9.1 Overview
  • 9.2 Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)
  • 9.3 Circulating Tumor Cells (CTC)
    • 9.3.1 Overview
    • 9.3.2 Circulating Tumor Cell (CTC): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Exosomes
    • 9.4.1 Overview
    • 9.4.2 Exosomes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Free Nucleic Acid
    • 9.5.1 Overview
  • 9.6 Free Nucleic Acid: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

10. Liquid Biopsy Market Analysis - By Application

  • 10.1 Overview
  • 10.2 Liquid Biopsy Market, by Application, 2019 and 2027 (%)
  • 10.3 Non-invasive Prenatal Testing (NIPT)
    • 10.3.1 Overview
    • 10.3.2 Noninvasive prenatal testing (NIPT): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Oncology
    • 10.4.1 Overview
    • 10.4.2 Oncology: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.5 Transplant Diagnostics
    • 10.5.1 Overview
    • 10.5.2 Transplant Diagnostics: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.6 Other Applications
    • 10.6.1 Overview
  • 10.7 Other applications: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

11. Liquid Biopsy Market Analysis - By End User

  • 11.1 Overview
  • 11.2 Liquid Biopsy Market, by End-User, 2019 and 2027 (%)
  • 11.3 Academic & Research Institutes
    • 11.3.1 Overview
    • 11.3.2 Academic & Research Institutes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.4 Hospitals
    • 11.4.1 Overview
    • 11.4.2 Hospitals: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.5 Reference Laboratories
    • 11.5.1 Overview
  • 11.6 Reference Laboratories: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • 11.7 Other End Users
    • 11.7.1 Overview
  • 11.8 Other End Users: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)

12. Liquid Biopsy Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 12.1 Europe Liquid Biopsy Market Revenue and Forecasts To 2027
    • 12.1.1 Overview
    • 12.1.2 Europe: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
    • 12.1.3 Europe: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
    • 12.1.4 Europe: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
    • 12.1.5 Europe: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
    • 12.1.6 Europe: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
    • 12.1.7 Europe: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.8 Europe: Liquid Biopsy Market, by Country, 2018 & 2027 (%)
    • 12.1.9 Germany: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.1 Germany: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.9.2 Germany: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.9.3 Germany: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.9.4 Germany: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.9.5 Germany: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.9.6 Germany: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.10 UK: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.1 UK: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.10.2 UK: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.10.3 UK: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.10.4 UK: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.10.5 UK: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.10.6 UK: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.11 France: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.11.1 France: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.11.2 France: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.11.3 France: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.11.4 France: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.11.5 France: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.11.6 France: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.12 Spain: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.12.1 Spain: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.12.2 Spain: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.12.3 Spain: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.12.4 Spain: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.12.5 Spain: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.12.6 Spain: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)
    • 12.1.13 Italy: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.13.1 Italy: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
      • 12.1.13.2 Italy: Liquid Biopsy Market, by Product & Service, 2018-2027 (USD Million)
      • 12.1.13.3 Italy: Liquid Biopsy Market, by Sample, 2018-2027 (USD Million)
      • 12.1.13.4 Italy: Liquid Biopsy Market, by Circulating Biomarker, 2018-2027 (USD Million)
      • 12.1.13.5 Italy: Liquid Biopsy Market, by Application, 2018-2027 (USD Million)
      • 12.1.13.6 Italy: Liquid Biopsy Market, by End User, 2018-2027 (USD Million)

13. Impact of COVID-19 Pandemic on Global Liquid Biopsy Market

  • 13.1 Europe: Impact Assessment of COVID-19 Pandemic

14. Company Profiles

  • 14.1 F. Hoffmann-la Roche ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Inivata Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 LungLife AI, Inc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Exosome Diagnostics
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 MDxHealth
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Liquid Biopsy Market, by Product & Service- Revenue and Forecast to 2027 (USD Million)
  • Table 2. Europe Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 3. Europe Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 4. Europe Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Europe Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
  • Table 7. Germany Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Germany Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Germany Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Germany Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Germany Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 12. UK Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 13. UK Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 14. UK Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 15. UK Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 16. UK Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Incidence, Mortality and Prevalence By Cancer Site, 2018, France
  • Table 18. France Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 19. France Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 20. France Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 21. France Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 22. France Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Incidence, Mortality and Prevalence By Cancer Site, 2018, Spain
  • Table 24. Spain Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Spain Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Spain Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
  • Table 30. Italy Liquid Biopsy Market, by Product & Service - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Italy Liquid Biopsy Market, by Sample - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Italy Liquid Biopsy Market, by Circulating Biomarker - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Italy Liquid Biopsy Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Italy Liquid Biopsy Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 1. Glossary of Terms, Europe Liquid Biopsy Market

List Of Figures

  • Figure 1. Liquid Biopsy Market Segmentation
  • Figure 2. Europe Liquid Biopsy Market Overview
  • Figure 3. Reagents & Kits Segment Held Largest Share Of Product & Services Segment in Liquid Biopsy Market
  • Figure 4. Germany Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Europe Liquid Biopsy Market- Leading Country Markets (US$ Mn)
  • Figure 7. Europe Liquid Biopsy Market - Europe PEST Analysis
  • Figure 8. Liquid Biopsy Market Impact Analysis of Drivers and Restraints
  • Figure 9. Europe Liquid Biopsy Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 10. Liquid Biopsy Market Revenue Share, by Product & Service (2019 and 2027)
  • Figure 11. Equipment: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 12. Reagents & Kits: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 13. Services: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 14. Liquid Biopsy Market, by Sample, 2019 and 2027 (%)
  • Figure 15. Blood Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. Urine Based: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. Other Samples: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Liquid Biopsy Market, by Circulating Biomarker, 2019 and 2027 (%)
  • Figure 19. Circulating Tumor Cell (CTC): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Exosomes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Free Nucleic Acid: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Liquid Biopsy Market, by Application, 2019 and 2027 (%)
  • Figure 23. Noninvasive prenatal testing (NIPT): Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Oncology: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Transplant Diagnostics: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Other applications: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Liquid Biopsy Market, by End-User, 2019 and 2027 (%)
  • Figure 28. Academic & Research Institutes: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Hospitals: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Reference Laboratories: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Other End Users: Liquid Biopsy Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Europe: Liquid Biopsy Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 33. Europe Liquid Biopsy Market Revenue and Forecast to 2027 (USD Million)
  • Figure 34. Europe: Liquid Biopsy Market, by Country, 2018 & 2027 (%)
  • Figure 35. Germany: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. UK: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. France: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Spain: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Italy: Liquid Biopsy Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Impact of COVID-19 Pandemic In European Country Marke
Back to Top